| GlaxoSmithKline AG - Zeffix, Filmtabletten |
| 54868 | | 01 | | Zeffix | | Filmtabletten | | J05AF05 | | Lamivudine | | 24.03.1999 | | |
|
| Composition |
| lamivudinum 100 mg, cellulosum microcristallinum, carboxymethylamylum natricum, magnesii stearas, Überzug: hypromellosum, macrogolum 400, polysorbatum 80, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto corresp. natrium 284 µg. |
| Packungsbestandteile |
| Coated tablets | | | | | Active Agent | Dose |
|---|
| Lamivudine | 100 mg |
| | BAG: Active Agent | Dose |
|---|
| Lamivudine | 100 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | (Rubrum) | | | | Carboxymethylamylum Natricum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Macrogol | 400 | | | Magnesii Stearas | | | | Polysorbatum 80 | | | | Pro Compresso Obducto | | |
| |
|
| Teilbarkeit |
| | Ja (keine Bruchrille) | | | | kA | | | | Ja | | | | -- | | | | Zur Sondenapplikation sind keine Daten vorhanden. Alternative: Suspension | | | | | |
|
|
